Follow The Filings

IMVT position history

The shares of Immunovant (IMVT) that DME Capital Management reported in each quarter’s 13F.

Equity, COM

Shares held by quarter

New Add Reduce Exit

  1. 2026 Q1: 93,520 shares, $2.3M, 0.07% of portfolio, New
  2. 2026 Q2: 93,520 shares, $3.6M, 0.09% of portfolio
  3. 2026 Q3: 70,140 shares, $2.4M, 0.07% of portfolio, Reduce −25.0%
Holdings date Value % of holdings Shares Filing date All 13F holders